Leave no-one behind: Why the language we use is crucial

Our words hold power, so we need to learn how to use them well. This blog discusses why complex terminology should be avoided when talking to patients.
The time is now: A closer look at the DEPICT and DIVERSE Trials Act

The Consolidated Appropriations Act of 2023 has opened a world of new opportunities for improving diversity in clinical trials. Find out how in this blog.
Steps towards breaking down religious and cultural barriers to clinical trial participation

People’s beliefs play a huge role in their approach to clinical trials. Read this blog to learn how you can overcome cultural barriers.
How do we build trust in clinical research?

A huge barrier to clinical trials has always been distrust. So what can we be doing to build this trust authentically with patients? Read this blog to find out.
Demand Diversity: More than a movement.

Read this blog to learn about what’s next for Demand Diversity
My degree apprenticeship journey

Read this blog to find out more about one colleagues degree apprenticeship journey, and why it might be the right choice for you too.
Together we can…Clinical Trials Day 2023

Clinical Trials Day is a great opportunity every year to take a moment to pause, and really think about the fantastic work we do as an industry, where we started, and where we hope to go.
The road to EDIRA is a road less travelled

Read this blog post to discover key learnings from the first ever EDIRA Conference 2023
Breaking down walls: Enhancing inclusive patient engagement

Explore the critical importance of timely and inclusive patient engagement in clinical trials. Discover how proper planning can yield invaluable insights and why late, tokenistic efforts can hinder trial success.
Is health technology as damaging for certain patient communities as it is beneficial to others?

Digital health innovations (DHIs) can be transformative for patients. It can empower people to take better control of their health, and make it easier to get the care they need. And yet, there’s a big problem…